Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global HPV Associated Disorders Market Outlook
The global HPV associated disorders market was estimated at almost USD 18.52 billion in 2023. The industry is further expected to grow at a CAGR of 5% during the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
With the increase in the incidences of HPV-related diseases and the improvement in its treatment procedures, the global HPV associated disorders industry is expected to witness a steady growth over the forecast period.
Market Segmentation
HPV is a viral infection that often triggers the growth of the skin or mucous membrane (warts). There are over 100 human papillomaviruses (HPV) varieties. Many forms of cancers have been related to HPV infection, including anus, penis, uterus, vulva, and back of the throat (oropharyngeal).
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global HPV associated disorders industry can be broadly categorised based on segments like indication, therapy, distributional channel, and region.
- Indication:
- Cervical Intraepithelial Neoplasia (CIN)
- Cervical Cancer
- Anal Intraepithelial Neoplasia (AIN)
- Anal Cancer
- Genital Warts
- Others
- Therapy:
- Prevention
- Treatment
- Distributional Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
The EMR report looks into the regional HPV associated disorders markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The increased government initiatives and the growing funding for cancer research are expected to aid the global HPV associated disorders industry. However, the increased investment in R&D associated with oncologic diseases offers significant growth opportunities for the industry growth in the future. The lack of knowledge regarding the diagnosis and treatment of such diseases and the high treatment costs are some factors that may hinder the industry growth over the forecast period.
Hospital pharmacies, among other distribution channels, are expected to account for the largest share in the industry owing to the growing expenditure in healthcare infrastructure in both the developing and underdeveloped economies. Region-wise, while North America leads the industry, the Asia Pacific is expected to grow at the highest CAGR over the forecast period owing to the development in the healthcare infrastructure in the region, along with the rising consumer expenditure power.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global HPV associated disorders industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche AG
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Biocon Limited
- AstraZeneca plc
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Indication |
|
| Breakup by Therapy |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global HPV associated disorders market reached a value of USD 18.52 billion in 2023.
The market is projected to grow at a CAGR of nearly 5% in the forecast period of 2024-2032.
The major drivers of the industry include rising disposable incomes, increasing population, rising investment in R&D, and the growing expenditure in the healthcare infrastructure.
The increased government initiatives and the rising funding for cancer research are expected to be the key trends guiding the growth of the industry.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the leading regions in the market, with North America dominating the market.
The leading indications segments in the industry include cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, and genital warts, among others.
The major therapies included in the market are prevention and treatment.
The significant distribution channels in the industry include hospital pharmacies, retail pharmacies, and online pharmacies.
The leading players in the market are F. Hoffmann-La Roche AG, Merck & Co., Inc., GlaxoSmithKline plc, Biocon Limited, and AstraZeneca plc, among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124